Synexus and University of Exeter Collaboration

The Synexus HealthyMinds Registry is a collaboration between the University of Exeter in the United Kingdom and Synexus, the clinical research sites of Accelerated Enrolment Solutions (AES) – a business of Pharmaceutical Product Development, LLC (PPD), the global contract research organization.

The research generated by this study will be used by the University of Exeter to better understand how the brain ages in order to identify new ways to reduce the risk of Alzheimer’s Disease and other forms of dementia so that people across the world can make improvements in their lives to benefit their brains. In addition, registry participants may be among the first to learn about clinical research studies of promising new treatments for Alzheimer’s and other forms of dementia, and may be afforded opportunities to join clinical trials managed by AES in communities surrounding its Synexus clinical research sites and major Alzheimer’s research facilities.


Synexus is dedicated to conducting clinical studies and has been investigating the effectiveness of new medicines and treatments for more than 20 years. At clinical research sites located on five continents throughout the world, highly trained doctors, nurses, and staff provide friendly, relaxed environments where patients help shape the future of health for themselves and others.

University of Exeter

The University of Exeter Medical School is improving health and well-being in the United Kingdom and across the world, through the development of high-quality graduates and world-leading research that has international impact. As part of the Russell Group of research-intensive UK universities, which includes Oxford and Cambridge, Exeter combines this world-class research with very high levels of student satisfaction. The medical school achieves its mission through swiftly turning new discoveries into treatment therapies. The University of Exeter Medical School works closely with the UK National Health Service as well as global funders and collaborators to ensure its innovations tackle complex global health care needs. For more information, visit